MetaVia (MTVA) Other financing activities (2016 - 2025)
MetaVia's (MTVA) quarterly Other financing activities came in at $6000.0 in Q2 2025, up 100.41% on a QoQ basis from -$1.5 million in Q4 2024.
MetaVia (MTVA) Other financing activities (2016 - 2025) Analysis & Trends
MetaVia (MTVA) has 9 years of Other financing activities data on file, last reported at $6000.0 in Q2 2025.
- Quarterly Other financing activities changed N/A year-over-year to $6000.0 in Q2 2025, while the trailing twelve-month figure through Dec 2025 was $6000.0 (up 100.41% YoY) and the FY2025 annual result came in at $6000.0, up 500.0% from the prior year.
- Other financing activities grew to $6000.0 in Q2 2025, from -$1.5 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $9.9 million in Q3 2021 to a low of -$7.9 million in Q4 2021.
- A 5-year average of $1.1 million and a median of $457000.0 in 2021 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 1613.21% in 2021, down 1332.24% in 2021.
- Tracing MTVA's Other financing activities over 5 years: stood at -$7.9 million in 2021, then soared by 168.64% to $5.4 million in 2022, then plunged by 224.36% to -$6.8 million in 2023, then jumped by 78.19% to -$1.5 million in 2024, then soared by 100.41% to $6000.0 in 2025.
- The last three Other financing activities figures came in at $6000.0 (Q2 2025), -$1.5 million (Q4 2024), and $1000.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | MetaVia | 8.72 Mn | -3.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -881,000.00 |
| Dec 31, 2025 | -881,000.00 |
| Sep 30, 2025 | 881,000.00 |
| Sep 30, 2025 | 881,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Dec 31, 2024 | -1.47 Mn |
| Dec 31, 2024 | -1.47 Mn |
| Sep 30, 2024 | 1,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Dec 31, 2023 | -6.75 Mn |
| Dec 31, 2023 | -6.75 Mn |
| Sep 30, 2023 | 6.75 Mn |
| Sep 30, 2023 | 6.75 Mn |
| Jun 30, 2023 | 5.40 Mn |
| Jun 30, 2023 | 5.40 Mn |
| Mar 31, 2023 | 1.44 Mn |
| Mar 31, 2023 | 1.44 Mn |
| Dec 31, 2022 | 5.43 Mn |
| Dec 31, 2022 | 5.43 Mn |